Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1994 Sep;72(3 Suppl):S46–S51. doi: 10.1136/hrt.72.3_suppl.s46

ACE inhibitors in non-diabetic renal disease

Richard J Fluck 1, Anthony E G Raine 1
PMCID: PMC1025592  PMID: 7946803

Full text

PDF
S46

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson S., Meyer T. W., Rennke H. G., Brenner B. M. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest. 1985 Aug;76(2):612–619. doi: 10.1172/JCI112013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson S., Rennke H. G., Brenner B. M. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest. 1986 Jun;77(6):1993–2000. doi: 10.1172/JCI112528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bianchi S., Bigazzi R., Baldari G., Campese V. M. Long-term effects of enalapril and nicardipine on urinary albumin excretion in patients with chronic renal insufficiency: a 1-year follow-up. Am J Nephrol. 1991;11(2):131–137. doi: 10.1159/000168289. [DOI] [PubMed] [Google Scholar]
  4. Bohrer M. P., Deen W. M., Robertson C. R., Brenner B. M. Mechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol. 1977 Jul;233(1):F13–F21. doi: 10.1152/ajprenal.1977.233.1.F13. [DOI] [PubMed] [Google Scholar]
  5. Brazy P. C., Stead W. W., Fitzwilliam J. F. Progression of renal insufficiency: role of blood pressure. Kidney Int. 1989 Feb;35(2):670–674. doi: 10.1038/ki.1989.37. [DOI] [PubMed] [Google Scholar]
  6. Brenner B. M., Meyer T. W., Hostetter T. H. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982 Sep 9;307(11):652–659. doi: 10.1056/NEJM198209093071104. [DOI] [PubMed] [Google Scholar]
  7. Brown M. A., Whitworth J. A. Hypertension in human renal disease. J Hypertens. 1992 Aug;10(8):701–712. [PubMed] [Google Scholar]
  8. Brunner F. P., Thiel G., Hermle M., Bock H. A., Mihatsch M. J. Long-term enalapril and verapamil in rats with reduced renal mass. Kidney Int. 1989 Dec;36(6):969–977. doi: 10.1038/ki.1989.289. [DOI] [PubMed] [Google Scholar]
  9. Böhler J., Woitas R., Keller E., Reetze-Bonorden P., Schollmeyer P. J. Effect of nifedipine and captopril on glomerular hyperfiltration in normotensive man. Am J Kidney Dis. 1992 Aug;20(2):132–139. doi: 10.1016/s0272-6386(12)80540-3. [DOI] [PubMed] [Google Scholar]
  10. Chapman A. B., Gabow P. A., Schrier R. W. Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease. Ann Intern Med. 1991 Nov 15;115(10):769–773. doi: 10.7326/0003-4819-115-10-769. [DOI] [PubMed] [Google Scholar]
  11. Choudhri A. H., Cleland J. G., Rowlands P. C., Tran T. L., McCarty M., al-Kutoubi M. A. Unsuspected renal artery stenosis in peripheral vascular disease. BMJ. 1990 Nov 24;301(6762):1197–1198. doi: 10.1136/bmj.301.6762.1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Curtis J. J., Luke R. G., Whelchel J. D., Diethelm A. G., Jones P., Dustan H. P. Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension. N Engl J Med. 1983 Feb 17;308(7):377–381. doi: 10.1056/NEJM198302173080707. [DOI] [PubMed] [Google Scholar]
  13. Farrow P. R., Wilkinson R. Reversible renal failure during treatment with captopril. Br Med J. 1979 Jun 23;1(6179):1680–1680. doi: 10.1136/bmj.1.6179.1680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ferder L. F., Inserra F., Daccordi H., Romano L., Fernández A., Tessler J. Effects of enalapril on renal parameters in patients with primary glomerulopathies associated with chronic renal failure. Drugs. 1990;39 (Suppl 2):40–46. doi: 10.2165/00003495-199000392-00008. [DOI] [PubMed] [Google Scholar]
  15. Glassock R. J. Focus on proteinuria. Am J Nephrol. 1990;10 (Suppl 1):88–93. doi: 10.1159/000168200. [DOI] [PubMed] [Google Scholar]
  16. Grazi G., Cirami C., Panichi V., Bianchi A. M., Parrini M., Baronti A., Cominotto R., Montagnani E., Palla R. Renal effects of enalapril in hypertensive patients with glomerulonephritis. Nephrol Dial Transplant. 1989;4(5):396–398. doi: 10.1093/oxfordjournals.ndt.a091898. [DOI] [PubMed] [Google Scholar]
  17. Harding M. B., Smith L. R., Himmelstein S. I., Harrison K., Phillips H. R., Schwab S. J., Hermiller J. B., Davidson C. J., Bashore T. M. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992 May;2(11):1608–1616. doi: 10.1681/ASN.V2111608. [DOI] [PubMed] [Google Scholar]
  18. Hoyer J., Schulte K. L., Lenz T. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure. Clin Pharmacokinet. 1993 Mar;24(3):230–254. doi: 10.2165/00003088-199324030-00005. [DOI] [PubMed] [Google Scholar]
  19. Hricik D. E., Browning P. J., Kopelman R., Goorno W. E., Madias N. E., Dzau V. J. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med. 1983 Feb 17;308(7):373–376. doi: 10.1056/NEJM198302173080706. [DOI] [PubMed] [Google Scholar]
  20. Ikeda T., Nakayama D., Gomi T., Sakurai J., Yamazaki T., Yuhara M. Captopril, an angiotensin I-converting enzyme inhibitor, decreases proteinuria in hypertensive patients with renal diseases. Nephron. 1989;52(1):72–75. doi: 10.1159/000185584. [DOI] [PubMed] [Google Scholar]
  21. Kalra P. A., Mamtora H., Holmes A. M., Waldek S. Renovascular disease and renal complications of angiotensin-converting enzyme inhibitor therapy. Q J Med. 1990 Oct;77(282):1013–1018. doi: 10.1093/qjmed/77.1.1013. [DOI] [PubMed] [Google Scholar]
  22. Kurkus J., Thysell H. Reduction of albuminuria after angiotensin converting enzyme inhibition in various renal disorders. Scand J Urol Nephrol. 1990;24(1):63–68. doi: 10.3109/00365599009180362. [DOI] [PubMed] [Google Scholar]
  23. Lee H. C., Pettinger W. A. Diuretics potentiate the angiotensin converting-enzyme inhibitor-associated acute renal dysfunction. Clin Nephrol. 1992 Oct;38(4):236–237. [PubMed] [Google Scholar]
  24. Luke R. G. Hypertension in renal transplant recipients. Kidney Int. 1987 Apr;31(4):1024–1037. doi: 10.1038/ki.1987.102. [DOI] [PubMed] [Google Scholar]
  25. Ma K. W., Greene E. L., Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis. 1992 Jun;19(6):505–513. doi: 10.1016/s0272-6386(12)80827-4. [DOI] [PubMed] [Google Scholar]
  26. Mailloux L. U., Bellucci A. G., Mossey R. T., Napolitano B., Moore T., Wilkes B. M., Bluestone P. A. Predictors of survival in patients undergoing dialysis. Am J Med. 1988 May;84(5):855–862. doi: 10.1016/0002-9343(88)90063-0. [DOI] [PubMed] [Google Scholar]
  27. Mann J. F., Reisch C., Ritz E. Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function. A retrospective study. Nephron. 1990;55 (Suppl 1):38–42. doi: 10.1159/000186033. [DOI] [PubMed] [Google Scholar]
  28. Miyamori I., Yasuhara S., Takeda Y., Koshida H., Ikeda M., Nagai K., Okamoto H., Morise T., Takeda R., Aburano T. Effects of converting enzyme inhibition on split renal function in renovascular hypertension. Hypertension. 1986 May;8(5):415–421. doi: 10.1161/01.hyp.8.5.415. [DOI] [PubMed] [Google Scholar]
  29. Pasternack A., Eklund J., Krohn K. Renal artery stenosis and the nephrotic syndrome. Acta Med Scand. 1967 Mar;181(3):265–268. doi: 10.1111/j.0954-6820.1967.tb15152.x. [DOI] [PubMed] [Google Scholar]
  30. Pettinger W. A., Lee H. C., Reisch J., Mitchell H. C. Long-term improvement in renal function after short-term strict blood pressure control in hypertensive nephrosclerosis. Hypertension. 1989 Jun;13(6 Pt 2):766–772. doi: 10.1161/01.hyp.13.6.766. [DOI] [PubMed] [Google Scholar]
  31. Raine A. E., Margreiter R., Brunner F. P., Ehrich J. H., Geerlings W., Landais P., Loirat C., Mallick N. P., Selwood N. H., Tufveson G. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant. 1992;7 (Suppl 2):7–35. [PubMed] [Google Scholar]
  32. Ruilope L. M., Miranda B., Morales J. M., Rodicio J. L., Romero J. C., Raij L. Converting enzyme inhibition in chronic renal failure. Am J Kidney Dis. 1989 Feb;13(2):120–126. doi: 10.1016/s0272-6386(89)80129-5. [DOI] [PubMed] [Google Scholar]
  33. Scoble J. E., Maher E. R., Hamilton G., Dick R., Sweny P., Moorhead J. F. Atherosclerotic renovascular disease causing renal impairment--a case for treatment. Clin Nephrol. 1989 Mar;31(3):119–122. [PubMed] [Google Scholar]
  34. Seelig C. B., Maloley P. A., Campbell J. R. Nephrotoxicity associated with concomitant ACE inhibitor and NSAID therapy. South Med J. 1990 Oct;83(10):1144–1148. doi: 10.1097/00007611-199010000-00007. [DOI] [PubMed] [Google Scholar]
  35. Swartbol P., Thorvinger B. O., Pärsson H., Norgren L. Renal artery stenosis in patients with peripheral vascular disease and its correlation to hypertension. A retrospective study. Int Angiol. 1992 Jul-Sep;11(3):195–199. [PubMed] [Google Scholar]
  36. Tielemans C., Madhoun P., Lenaers M., Schandene L., Goldman M., Vanherweghem J. L. Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors. Kidney Int. 1990 Nov;38(5):982–984. doi: 10.1038/ki.1990.301. [DOI] [PubMed] [Google Scholar]
  37. Tolins J. P., Raij L. Antihypertensive therapy and the progression of chronic renal disease. Are there renoprotective drugs? Semin Nephrol. 1991 Sep;11(5):538–548. [PubMed] [Google Scholar]
  38. Traindl O., Falger S., Reading S., Banyai M., Liebisch B., Gisinger J., Templ E., Mayer G., Kovarik J. The effects of lisinopril on renal function in proteinuric renal transplant recipients. Transplantation. 1993 Jun;55(6):1309–1313. doi: 10.1097/00007890-199306000-00019. [DOI] [PubMed] [Google Scholar]
  39. Wight J. P., Brown C. B., el Nahas A. M. Effect of control of hypertension on progressive renal failure. Clin Nephrol. 1993 Jun;39(6):305–311. [PubMed] [Google Scholar]
  40. Wing A. J., Broyer M., Brunner F. P., Brynger H., Challah S., Donckerwolcke R. A., Gretz N., Jacobs C., Kramer P., Selwood N. H. Combined report on regular dialysis and transplantation in Europe, XIII, 1982. Proc Eur Dial Transplant Assoc. 1983;20:2–75. [PubMed] [Google Scholar]
  41. Yoshida Y., Fogo A., Shiraga H., Glick A. D., Ichikawa I. Serial micropuncture analysis of single nephron function in subtotal renal ablation. Kidney Int. 1988 Apr;33(4):855–867. doi: 10.1038/ki.1988.77. [DOI] [PubMed] [Google Scholar]
  42. Zucchelli P., Zuccalà A., Borghi M., Fusaroli M., Sasdelli M., Stallone C., Sanna G., Gaggi R. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int. 1992 Aug;42(2):452–458. doi: 10.1038/ki.1992.309. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES